Physician
New Mexico Oncology Hematology Consultants, LTD.
New Mexico Oncology Hematology Consultants, LTD. was paid $4.19M by Medicaid between Jan 2018 and Dec 2024, across 60 billing codes. Its largest line is 99215, doctor's office visit, returning patient (complex) — 31% of everything it billed.
33Billing provider infoNEW MEXICO ONCOLOGY HEMATOLOGY CONSULTANTS, LTD.
ALBUQUERQUE, NM 87109
ALBUQUERQUE, NM 87109
33aNPI1164475232assigned 05/18/2006
33bProvider typeRadiation Oncology Physician
28Total paid$4.19M
24GClaims70,112
24DCodes billed60
24AFirst – last monthJan 2018 – Dec 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 8,067 | $454K | |
| 2019 | 6,120 | $341K | |
| 2020 | 8,731 | $536K | |
| 2021 | 13,046 | $747K | |
| 2022 | 13,468 | $795K | |
| 2023 | 8,887 | $572K | |
| 2024incomplete | 11,793 | $745K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 31% | 13,841 | 12,369 | $1.29M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 22% | 14,096 | 13,372 | $918K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 13% | 6,641 | 5,273 | $538K |
| 78815 | Positron emission tomography (PET) for limited area imaging | 8.0% | 298 | 280 | $335K |
| 96367 | 3.1% | 3,957 | 3,025 | $131K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.9% | 708 | 659 | $120K |
| 77014 | 2.5% | 1,279 | 369 | $104K | |
| G6015 | Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | 2.4% | 438 | 111 | $102K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 1.8% | 764 | 712 | $76K |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 1.7% | 257 | 248 | $73K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.4% | 3,188 | 2,420 | $58K |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 1.2% | 553 | 230 | $49K |
48 more codes
| 99205 | Prolong outpt/office vis | 1.1% | 291 | $45K |
| 77427 | 1.0% | 373 | $44K | |
| S9999 | Sales tax | <1% | 725 | $38K |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 3,511 | $37K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 669 | $36K |
| J2469 | Injection, palonosetron hcl, 25 mcg | <1% | 1,374 | $31K |
| 77336 | <1% | 411 | $20K | |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 348 | $15K |
| 94060 | <1% | 354 | $13K | |
| 99442 | <1% | 154 | $11K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 95 | $11K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 2,244 | $10K |
| 96523 | <1% | 464 | $7K | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 6,349 | $7K |
| 96415 | <1% | 296 | $7K | |
| 73130 | <1% | 95 | $6K | |
| 77334 | <1% | 31 | $6K | |
| 94618 | <1% | 218 | $5K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 113 | $4K |
| 96416 | <1% | 35 | $4K | |
| 94726 | <1% | 108 | $4K | |
| 94729 | <1% | 107 | $4K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,252 | $4K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 154 | $3K |
| 99245 | <1% | 14 | $3K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 2,566 | $3K |
| 99358 | Prolong nursin fac eval 15m | <1% | 46 | $2K |
| J0640 | Injection, leucovorin calcium, per 50 mg | <1% | 52 | $2K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 208 | $2K |
| 99443 | <1% | 13 | $2K | |
| J9190 | Injection, fluorouracil, 500 mg | <1% | 56 | $2K |
| 20610 | <1% | 25 | $2K | |
| 96417 | <1% | 48 | $1K | |
| 73630 | <1% | 29 | $1K | |
| 92511 | <1% | 12 | $1K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 192 | $1K |
| 96401 | <1% | 14 | $756.81 | |
| 81003 | <1% | 437 | $491.16 | |
| 96402 | <1% | 13 | $355.50 | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 27 | $261.44 |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | <1% | 13 | $258.71 |
| 96368 | <1% | 16 | $185.14 | |
| A9585 | Injection, gadobutrol, 0.1 ml | <1% | 51 | $92.24 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 91 | $74.04 |
| 85610 | <1% | 16 | $34.42 | |
| 81002 | <1% | 14 | $30.52 | |
| 99072 | <1% | 351 | $18.40 | |
| 94761 | <1% | 17 | $4.63 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMCANENY, BARBARA (CEO)